Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för 4-hydroxy-N,1-dimethyl-2-oxo-N-phenyl-3-quinolinecarboxamide. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

11 träffar

Bibliografisk träff 2023-07-19

A preclinical secondary pharmacology resource illuminates target-adverse drug reaction associations of marketed drugs.

Sutherland JJ, Yonchev D, Fekete A, Urban L.

Nat Commun · research support, non-u.s. gov't; research-article; journal article · DOI 10.1038/s41467-023-40064-9

Bibliografisk träff 2022-11-04

Discovery of 1-hydroxy-2-methylquinolin-4(1H)-one derivatives as new cytochrome bd oxidase inhibitors for tuberculosis therapy.

Zhou Y, Shao M, Wang W, Cheung CY, Wu Y, Yu H, Hu X, Cook GM, Gong H, Lu X.

Eur J Med Chem · journal article · DOI 10.1016/j.ejmech.2022.114896

Bibliografisk träff 2013-08-16

A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.

Morgan RE, van Staden CJ, Chen Y, Kalyanaraman N, Kalanzi J, Dunn RT, Afshari CA, Hamadeh HK.

Toxicol Sci · journal article · DOI 10.1093/toxsci/kft176

Bibliografisk träff 2010-02-01

Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.

Varma MV, Obach RS, Rotter C, Miller HR, Chang G, Steyn SJ, El-Kattan A, Troutman MD.

J Med Chem · journal article · DOI 10.1021/jm901371v

Bibliografisk träff 2008-04-21

Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.

Obach RS, Lombardo F, Waters NJ.

Drug Metab Dispos · journal article · DOI 10.1124/dmd.108.020479

Bibliografisk träff 2005-06-01

Design, synthesis, and biological evaluation of novel 4-hydro-quinoline-3-carboxamide derivatives as an immunomodulator.

He JF, Yun LH, Yang RF, Xiao ZY, Cheng JP, Zhou WX, Zhang YX.

Bioorg Med Chem Lett · comparative study; research support, non-u.s. gov't; journal article · DOI 10.1016/j.bmcl.2005.04.040

Bibliografisk träff 2004-04-01

Synthesis and biological evaluation of new 1,2-dihydro-4-hydroxy-2-oxo-3-quinolinecarboxamides for treatment of autoimmune disorders: structure-activity relationship.

Jönsson S, Andersson G, Fex T, Fristedt T, Hedlund G, Jansson K, Abramo L, Fritzson I, Pekarski O, Runström A, Sandin H, Thuvesson I, Björk A.

J Med Chem · comparative study; journal article · DOI 10.1021/jm031044w

Bibliografisk träff 2003-03-01

Structure-activity relationships studies of the anti-angiogenic activities of linomide.

Shi J, Xiao Z, Ihnat MA, Kamat C, Pandit B, Hu Z, Li PK.

Bioorg Med Chem Lett · journal article · DOI 10.1016/s0960-894x(03)00047-7

Bibliografisk träff 2002-09-01

Quinoline-3-carbothioamides and related compounds as novel immunomodulating agents.

Tojo T, Spears GW, Tsuji K, Nishimura H, Ogino T, Seki N, Sugiyama A, Matsuo M.

Bioorg Med Chem Lett · journal article · DOI 10.1016/s0960-894x(02)00377-3

Bibliografisk träff 2002-01-01

Synthesis and antinephritic activities of quinoline-3-carboxamides and related compounds.

Tsuji K, Spears GW, Nakamura K, Tojo T, Seki N, Sugiyama A, Matsuo M.

Bioorg Med Chem Lett · journal article · DOI 10.1016/s0960-894x(01)00671-0

Bibliografisk träff 2001-02-01

Modified synthesis and antiangiogenic activity of linomide.

Khan SR, Mhaka A, Pili R, Isaacs JT.

Bioorg Med Chem Lett · research support, u.s. gov't, p.h.s.; research support, non-u.s. gov't; journal article · DOI 10.1016/s0960-894x(00)00699-5